Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",48290,289,1.12 [0.92-1.37],0.2451331066432158
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50025,382,1.15 [0.97-1.36],0.1135693878489079
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49497,2686,1.16 [1.09-1.23],7.389038121672554e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,50062,830,1.14 [1.02-1.28],0.0220862250503103
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,48538,6825,1.12 [1.08-1.17],2.199615514781601e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),48743,6260,1.20 [1.15-1.25],7.092298047622275e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,49577,2382,1.13 [1.06-1.21],0.0003434949071994
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,49887,169,1.15 [0.90-1.48],0.2636558426755069
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46045,1887,1.18 [1.09-1.27],2.518124489433875e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44512,2155,1.20 [1.12-1.29],3.6624700872093773e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,44238,496,1.31 [1.13-1.50],0.0002170164084116
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35195,3875,1.22 [1.16-1.28],1.6288243029736566e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43953,759,1.34 [1.20-1.51],5.621130178280648e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,49990,2795,1.13 [1.07-1.21],8.857480961013454e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Mycoses,50209,977,1.14 [1.03-1.26],0.0154305028457223
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48616,1805,1.17 [1.08-1.27],5.854293945451288e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,50081,2080,1.16 [1.08-1.24],6.658043018795419e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47578,383,1.15 [0.97-1.36],0.1026082501545121
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,50308,99,0.96 [0.68-1.36],0.831990963569214
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,49823,1822,1.17 [1.08-1.26],8.564737471716013e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,49864,146,1.09 [0.82-1.44],0.5505798397022348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50151,304,1.32 [1.10-1.59],0.0031533502158582
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50115,268,1.27 [1.04-1.55],0.0195728834355409
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47629,818,1.15 [1.03-1.30],0.0152597878902052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,47344,533,1.20 [1.04-1.38],0.0141151209430396
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,47405,210,1.14 [0.91-1.43],0.2513954118350915
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,50264,100,0.98 [0.70-1.38],0.928595373311478
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50181,292,1.18 [0.97-1.43],0.1041248584290156
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral warts,49987,98,1.08 [0.76-1.53],0.661959413105921
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],50010,121,1.15 [0.84-1.56],0.3766876285146046
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,49733,574,0.99 [0.86-1.15],0.9410996988266782
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50134,114,1.11 [0.81-1.53],0.5145918743790868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50100,122,0.90 [0.66-1.24],0.5321358368570566
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23124,127,1.00 [0.73-1.36],0.9810586207199424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",49658,2802,1.08 [1.01-1.15],0.0158602304828565
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of meninges,50281,111,1.42 [1.05-1.91],0.0225470020479157
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50182,126,0.90 [0.65-1.23],0.5051684170402391
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,50258,202,1.32 [1.06-1.65],0.0139647083110033
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of ovary,27056,171,1.29 [1.00-1.66],0.0517185499172498
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,50261,698,1.01 [0.89-1.15],0.8567721839526117
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Caecum,50263,587,0.97 [0.84-1.12],0.6353372960949815
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50093,139,1.28 [0.98-1.67],0.0705390240163483
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,50258,421,1.11 [0.95-1.31],0.19214636307921
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Rectum,50183,682,1.16 [1.02-1.32],0.0209170686323236
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50083,1197,1.14 [1.04-1.26],0.0072141544224291
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,50245,837,1.10 [0.98-1.23],0.1145001320551562
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Carcinoma in situ of breast,22008,134,1.03 [0.75-1.40],0.8682378714029048
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22099,164,1.13 [0.86-1.49],0.3735065489980506
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",40089,100,1.47 [1.07-2.01],0.0175131897621217
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",40123,134,1.05 [0.78-1.42],0.7598295309037894
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50211,230,0.92 [0.73-1.16],0.4642476506066594
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma, any site",50212,226,0.94 [0.74-1.19],0.6026940702384205
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Leiomyoma of uterus,26159,574,0.90 [0.77-1.05],0.1723233241626225
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lung cancer and mesothelioma,34911,647,2.05 [1.86-2.26],4.92330864248896e-47
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lymphoid leukaemia,40089,100,1.47 [1.07-2.01],0.0180036423251284
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40357,368,1.05 [0.88-1.26],0.5897299412166057
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",40382,393,1.00 [0.84-1.19],0.9924446913465944
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22228,185,1.14 [0.89-1.47],0.306870756775045
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",40144,155,0.89 [0.67-1.18],0.4103918771337477
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",40195,206,1.13 [0.90-1.42],0.2791096864221952
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",40177,188,1.07 [0.84-1.35],0.5755963075481698
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22182,139,1.28 [0.97-1.68],0.0825667597810841
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",40169,180,0.81 [0.62-1.06],0.1321270569385293
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19303,1357,1.02 [0.93-1.12],0.7309044743666633
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",40207,218,1.19 [0.95-1.49],0.1220242708059737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40131,142,1.04 [0.78-1.37],0.8083788525231027
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,40196,207,1.30 [1.04-1.63],0.0224582049518187
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi,49928,393,1.02 [0.85-1.21],0.8603896930595253
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi of trunk,50232,169,0.97 [0.74-1.27],0.8193279745955724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanoma in situ,40055,159,0.98 [0.74-1.30],0.9038023555470224
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",40165,176,1.11 [0.86-1.44],0.4198863575095922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40301,312,1.22 [1.01-1.48],0.037042735867898
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",40432,443,1.53 [1.35-1.74],9.486644816439211e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",40180,191,1.43 [1.13-1.79],0.0024180068393605
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Other benign neoplasms of skin,49951,293,1.25 [1.03-1.52],0.0252666667954889
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",42080,2091,1.05 [0.97-1.13],0.2540026420303822
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",42193,2204,1.04 [0.97-1.12],0.2756708189431521
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49747,661,1.08 [0.95-1.23],0.2627490991052308
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,46623,218,1.08 [0.86-1.36],0.4959709343014754
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,49221,135,1.29 [0.98-1.71],0.0711190285248946
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,48763,5639,1.09 [1.05-1.15],8.38708727879138e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,47437,96,1.13 [0.81-1.57],0.4790294579236609
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,49492,100,1.25 [0.90-1.73],0.1784517357467101
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,49357,2952,1.13 [1.06-1.20],8.105359186563869e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,49356,2951,1.13 [1.06-1.20],0.000134877956786
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,46573,168,1.36 [1.07-1.73],0.0123338218037854
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49670,2329,1.13 [1.06-1.21],0.000456944852365
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,49616,224,1.37 [1.11-1.70],0.0040854123240912
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,49209,123,1.15 [0.86-1.54],0.3372759959392605
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,49202,116,1.38 [1.03-1.84],0.0312369256930511
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,49933,541,1.26 [1.10-1.45],0.0011709838422415
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,50102,107,1.29 [0.94-1.78],0.1161231983713155
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",49838,446,1.24 [1.07-1.45],0.0054604321992994
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,47546,205,0.92 [0.72-1.18],0.5258923684130825
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,38900,616,1.34 [1.18-1.52],6.288893790474518e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,46907,225,0.96 [0.76-1.23],0.7693116611941705
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,46926,244,1.11 [0.94-1.31],0.2022566416975252
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,38392,108,1.24 [0.91-1.69],0.1754479518855948
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,46722,133,1.29 [0.99-1.68],0.0642827822470881
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,45623,463,1.21 [1.04-1.41],0.0158916880165107
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",49375,1115,1.13 [1.02-1.25],0.014703531049324
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,48783,523,0.94 [0.80-1.09],0.4126749190258183
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,48514,254,0.92 [0.74-1.15],0.4654800330110297
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,49617,3028,1.07 [1.00-1.13],0.0426215848177373
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,43804,2934,1.09 [1.03-1.16],0.0043909586399249
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",38415,131,1.34 [1.01-1.77],0.0397444942218675
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",46377,155,1.06 [0.80-1.39],0.6962328254391077
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,38831,547,1.13 [0.98-1.31],0.0829960248772588
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,38401,117,1.31 [0.96-1.78],0.0883794552148669
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,45181,6897,1.07 [1.03-1.12],0.0007636160262917
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,38658,374,1.24 [1.05-1.47],0.0118616617573513
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,39366,1082,1.17 [1.05-1.29],0.0027774873262409
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50146,628,1.25 [1.09-1.42],0.0009301917552033
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,49779,261,1.03 [0.83-1.28],0.762785642050669
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,38534,250,1.09 [0.88-1.36],0.4137841553461262
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",38401,117,1.23 [0.90-1.67],0.1890365793527023
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,49251,3029,1.08 [1.02-1.15],0.01205834111328
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,38789,505,1.56 [1.36-1.78],6.043461987235273e-11
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,38863,579,1.38 [1.21-1.57],1.7764417575747917e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39520,1236,1.15 [1.05-1.27],0.0034350509994672
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,38518,234,0.99 [0.79-1.24],0.9128781232985288
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,49763,245,0.96 [0.77-1.21],0.7421807559363595
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,39468,1184,1.16 [1.05-1.28],0.0024739873360172
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,39229,945,1.15 [1.03-1.28],0.0141410993414475
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,45298,138,1.12 [0.84-1.49],0.4548299717578257
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,47998,9714,1.10 [1.06-1.14],6.758916072036271e-08
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,46319,97,1.66 [1.24-2.23],0.0007398472105509
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,46332,110,1.10 [0.79-1.52],0.581296076564794
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,49944,3789,1.10 [1.04-1.16],0.0008543212139802
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",49945,3783,1.10 [1.04-1.16],0.0009216472343076
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,46324,102,1.51 [1.12-2.04],0.0076099222593185
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,49639,2348,1.12 [1.04-1.20],0.0014392125455726
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",41378,3094,1.20 [1.13-1.27],2.8604931023772162e-09
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,50282,442,1.12 [0.96-1.31],0.1444080841789841
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,48422,162,1.51 [1.20-1.91],0.0005183258349403
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,47491,200,0.98 [0.77-1.25],0.8868736049099861
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,47566,275,0.80 [0.65-1.00],0.0497530474467815
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",38611,327,1.13 [0.93-1.37],0.2135866803453456
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45793,298,1.08 [0.89-1.31],0.4364496944508206
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4103,164,1.19 [0.93-1.54],0.1701152995803261
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4377,493,0.91 [0.78-1.06],0.2318904605422708
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,45615,120,1.00 [0.74-1.35],0.9925658801941296
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4047,111,1.13 [0.83-1.55],0.4257997765319895
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,49060,3565,1.02 [0.97-1.08],0.4048293347747186
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,48956,696,1.12 [0.99-1.27],0.0722361874858756
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,45871,711,1.19 [1.05-1.35],0.0062044747324625
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39787,1503,1.20 [1.10-1.31],2.598688740946731e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50084,478,1.13 [0.97-1.31],0.1242431044938799
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),48130,321,1.54 [1.31-1.81],1.071224016129264e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,45927,2326,1.17 [1.09-1.26],6.236775914148271e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,48279,470,1.38 [1.20-1.58],7.786700836465362e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,47925,116,1.60 [1.24-2.07],0.0003558790790548
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",48199,390,1.76 [1.54-2.02],3.811771989304669e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31198,3703,1.21 [1.14-1.27],6.283569722048426e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,AV-block,42394,833,1.11 [0.99-1.25],0.0844967093291242
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",50193,826,1.07 [0.95-1.20],0.2527530236552704
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,27874,379,1.36 [1.16-1.60],0.0001754462930023
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41892,331,1.25 [1.04-1.49],0.0169400478223942
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",41748,187,0.98 [0.76-1.26],0.8652227092510453
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,50305,100,1.41 [1.04-1.91],0.0269662913464051
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Conduction disorders,43594,2033,1.15 [1.07-1.24],0.0001613253676348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47630,4062,1.20 [1.14-1.27],1.6721606499406829e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,43878,14700,1.05 [1.02-1.08],0.0003027330295501
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47615,517,1.13 [0.98-1.31],0.1003068129047155
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Endocarditis,41704,143,1.52 [1.18-1.96],0.0013183644516529
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49905,2138,1.28 [1.19-1.37],2.98160525944714e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertension,45663,12639,1.03 [1.00-1.06],0.0441878685231981
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",45697,12673,1.03 [1.00-1.06],0.0590461119741425
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",49977,145,1.14 [0.87-1.49],0.3505824608373502
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33365,341,1.92 [1.69-2.19],2.340456179396987e-22
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33291,267,1.36 [1.13-1.63],0.0010429328346868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,50022,2296,1.26 [1.18-1.35],1.3424643384111648e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,48511,213,1.06 [0.84-1.34],0.6074607483840055
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47954,4353,1.17 [1.11-1.23],2.325108674518705e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49573,1085,1.21 [1.10-1.33],0.0001289121289559
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,42262,701,1.25 [1.10-1.41],0.000540046399507
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49375,1637,1.27 [1.17-1.37],3.6102719390609214e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44986,1385,1.33 [1.22-1.44],7.272687139635119e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50128,297,1.43 [1.20-1.71],5.0924773695356353e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",50251,609,1.24 [1.08-1.41],0.001508710627972
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,47200,102,1.03 [0.73-1.45],0.8621513652533872
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other aneurysm,47959,150,1.16 [0.89-1.51],0.2782107394208305
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,42385,824,1.14 [1.01-1.28],0.0304039906805387
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48006,197,1.50 [1.23-1.83],8.446391260004242e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48267,458,1.43 [1.24-1.65],6.134642841049532e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,41910,349,1.51 [1.28-1.78],7.673339913506114e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,47290,192,1.09 [0.85-1.38],0.5037295005260032
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,47190,92,0.99 [0.70-1.40],0.9571494974529556
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,47508,122,1.03 [0.75-1.41],0.850570700461387
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,47360,262,1.20 [0.98-1.47],0.0703359119392811
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43570,2009,1.28 [1.19-1.38],2.7959539824777296e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,47832,106,0.93 [0.67-1.30],0.6871035603914156
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48860,1051,1.44 [1.31-1.58],9.280956596138112e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49108,673,1.86 [1.68-2.06],9.649269398299609e-34
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",48577,1191,1.07 [0.97-1.18],0.1887876853226364
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28155,660,1.23 [1.08-1.40],0.001453268865555
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48533,782,1.52 [1.37-1.68],2.002696602276984e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47772,674,1.14 [1.00-1.29],0.0462798674461123
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,49358,923,1.25 [1.12-1.39],4.031131883890903e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50170,1281,1.27 [1.16-1.39],2.3194064036733266e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,42239,678,1.15 [1.01-1.31],0.0307324832414431
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49099,664,1.87 [1.69-2.07],6.2666211700320785e-34
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,47765,379,1.31 [1.11-1.53],0.0011235274784322
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49550,1252,1.20 [1.09-1.31],0.0001184433481945
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49509,1326,1.20 [1.10-1.31],5.5611459394048105e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,48459,116,1.18 [0.88-1.58],0.2638552592164089
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,47965,157,1.30 [1.01-1.69],0.0428880038948635
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48948,460,1.12 [0.96-1.31],0.1520184655599503
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48240,502,1.26 [1.09-1.45],0.0017846548548958
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Varicose veins,47923,825,1.01 [0.90-1.14],0.8688225282101035
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,47838,170,1.14 [0.89-1.46],0.3013646886837273
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,49860,1458,1.17 [1.08-1.28],0.0003045792812788
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50071,697,0.96 [0.85-1.09],0.5431393039948768
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",43994,2774,1.14 [1.07-1.22],3.485713936487014e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,49031,7811,1.14 [1.10-1.18],4.542059666720095e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49979,823,0.99 [0.88-1.10],0.8099443696667683
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",44304,3084,1.11 [1.04-1.18],0.0008812621916157
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41398,178,1.03 [0.80-1.32],0.8415419782644074
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,49269,2678,1.60 [1.53-1.68],1.4424092088740459e-92
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",44402,3182,1.27 [1.21-1.34],1.6240236667987553e-21
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Vascular dementia,49302,250,1.10 [0.89-1.36],0.3667773344943174
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Alzheimer disease,50307,647,0.95 [0.83-1.09],0.4659490869176204
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",33904,115,1.18 [0.87-1.60],0.2922907529735774
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Bell's palsy,46846,156,1.04 [0.79-1.37],0.7808322110874812
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47634,944,1.03 [0.93-1.16],0.5530196900232748
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral cysts,49521,451,1.08 [0.92-1.27],0.3287089096437102
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,50151,628,1.17 [1.03-1.33],0.0166889652034745
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,49326,96,0.95 [0.67-1.35],0.7691791779698978
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,50276,119,1.14 [0.84-1.56],0.394448780746622
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",49212,142,1.09 [0.82-1.45],0.546844672205341
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Epilepsy,47263,555,1.03 [0.89-1.19],0.7029341788529677
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49365,2657,1.07 [1.00-1.14],0.0598088799885628
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,50223,1183,0.95 [0.86-1.06],0.3681118544915824
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,49148,5046,1.07 [1.02-1.12],0.0073401615354202
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,49567,104,1.15 [0.83-1.59],0.3968961395124946
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hemiplegia,50012,489,1.25 [1.08-1.44],0.0025953333855983
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hydrocephalus,49192,122,1.27 [0.95-1.69],0.1002223855728802
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,50270,129,1.31 [0.99-1.74],0.0621002251888765
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,46833,143,1.02 [0.76-1.37],0.9079299949174258
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,46842,152,1.42 [1.11-1.81],0.0057672905213235
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Memory loss,49020,214,0.86 [0.67-1.10],0.2271094894549457
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Migraine,47407,699,1.11 [0.98-1.27],0.1108277189691702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",50168,629,1.12 [0.97-1.28],0.1138581035033749
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Motor neuron disease,34090,264,1.02 [0.82-1.27],0.8590486666659802
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,49985,202,1.14 [0.91-1.43],0.2561161186799549
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48999,2309,1.06 [0.99-1.14],0.115906732706227
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,47424,7330,1.05 [1.01-1.10],0.0122653331396642
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,49626,396,1.06 [0.90-1.26],0.4785015035071592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47494,804,1.02 [0.91-1.15],0.713612864569295
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",50159,572,1.20 [1.04-1.37],0.0106262865096812
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40019,1266,1.03 [0.93-1.13],0.5953681431343631
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,49214,144,1.01 [0.76-1.35],0.9230008158557176
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,49343,273,0.90 [0.73-1.11],0.3134260947556486
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,49363,323,1.19 [0.99-1.43],0.0625631953687507
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,46873,183,1.04 [0.81-1.35],0.7418555262152116
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other headache syndromes,46816,108,1.07 [0.77-1.49],0.7035034738898917
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other neurological diseases,50079,1009,1.05 [0.94-1.17],0.3713188024361886
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other sleep disorders,47790,1082,1.04 [0.93-1.15],0.5163288593766526
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Parkinson's disease,50261,834,0.94 [0.83-1.06],0.3211287009750742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,49179,109,0.78 [0.54-1.11],0.1688184637489113
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,50306,154,1.18 [0.91-1.54],0.2172225171952813
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Sleep apnoea,49831,931,1.05 [0.93-1.17],0.4315418893016167
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,49680,93,1.32 [0.94-1.84],0.1096468614072303
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,50282,316,0.99 [0.82-1.21],0.9574275959903912
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,46787,97,0.98 [0.69-1.40],0.9277352122343088
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,50307,654,0.94 [0.82-1.08],0.414587011013089
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),49231,243,1.12 [0.91-1.39],0.2972065641835436
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,49195,194,1.22 [0.97-1.54],0.0960837742112143
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,49517,773,1.10 [0.97-1.24],0.1390718799031153
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49965,457,0.76 [0.64-0.90],0.0012802938867836
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,48355,103,1.09 [0.78-1.52],0.6307678445535463
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48366,114,1.18 [0.86-1.61],0.3086489330972295
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",50099,95,0.91 [0.64-1.31],0.6267810133433505
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,49794,287,1.09 [0.89-1.33],0.4127555534853214
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4058,119,1.18 [0.87-1.59],0.2873564536818642
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4926,195,1.20 [0.95-1.51],0.1200408525674467
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,49180,179,1.18 [0.92-1.51],0.1980992990712816
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,49887,2026,0.88 [0.81-0.96],0.0022413733381295
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49591,1339,1.14 [1.04-1.24],0.0066945118902567
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48689,437,1.15 [0.98-1.35],0.0897559810480502
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50142,1398,1.03 [0.94-1.13],0.499342740641939
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,50287,132,1.10 [0.82-1.47],0.5363991219456063
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,49999,1255,1.04 [0.94-1.14],0.467184660087681
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",50223,716,1.03 [0.90-1.17],0.6655942688933105
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,50126,348,0.87 [0.72-1.05],0.1523906904391332
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,48366,114,1.22 [0.90-1.66],0.2050224311247463
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,48380,128,0.96 [0.71-1.30],0.7988836370205707
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,48361,109,1.19 [0.86-1.65],0.2883645036719303
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50129,1373,1.02 [0.93-1.12],0.7093819169980501
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,49114,358,1.10 [0.92-1.32],0.2843101444546997
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,48838,94,0.67 [0.46-1.00],0.0482865544105917
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,49701,194,0.90 [0.70-1.17],0.4285342726184181
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,50041,534,1.08 [0.93-1.25],0.3085029614528136
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,49117,373,1.00 [0.83-1.20],0.98590056333597
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,49993,215,0.84 [0.65-1.08],0.172481839466604
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49671,915,1.03 [0.92-1.16],0.5795512993899106
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,49276,275,0.91 [0.74-1.13],0.3939737391143586
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,47171,4199,0.99 [0.94-1.05],0.8288439462964727
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,49970,463,0.99 [0.84-1.17],0.9019078409327616
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,50267,297,1.06 [0.87-1.30],0.5474897451724614
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49036,784,1.14 [1.02-1.29],0.0273114636944673
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,49632,125,1.04 [0.76-1.41],0.8026889393375467
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,50263,108,1.07 [0.77-1.49],0.6756405301698278
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,48415,163,1.12 [0.86-1.47],0.3986828293139731
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48537,285,1.28 [1.06-1.55],0.0097727488101166
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,48093,232,0.80 [0.63-1.02],0.0721013225731578
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,48864,120,1.02 [0.74-1.40],0.912072839558004
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",47980,119,0.79 [0.56-1.11],0.1715416529469867
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,48924,168,1.12 [0.86-1.45],0.3976301301931305
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",49135,379,0.92 [0.76-1.10],0.358579166977558
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,48495,243,1.20 [0.97-1.49],0.0937142346501374
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,48075,214,0.81 [0.63-1.05],0.1167130389677768
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,48024,163,1.04 [0.80-1.36],0.7666613197331079
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,46489,3517,1.08 [1.02-1.15],0.0075716217637978
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,48392,140,1.12 [0.83-1.49],0.4571934280740555
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49803,802,1.08 [0.96-1.22],0.2043302932311336
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,49115,114,1.32 [0.98-1.76],0.063621075168938
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),49332,331,1.08 [0.90-1.30],0.427599548409444
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,49895,170,0.86 [0.65-1.15],0.3111591715992261
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,50216,234,0.93 [0.74-1.17],0.5419548329199164
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,50051,244,0.98 [0.78-1.22],0.8548753786240952
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,49838,113,1.52 [1.14-2.03],0.0040466388076028
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,49842,117,1.14 [0.84-1.56],0.4032125966357448
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,50108,1742,1.00 [0.92-1.09],0.9484963170845429
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,49615,1249,1.04 [0.94-1.15],0.4172669448584087
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,48610,244,0.75 [0.59-0.95],0.0177685791103835
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,48534,168,1.01 [0.77-1.32],0.9506180666002836
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,49832,143,1.47 [1.14-1.90],0.0032803341061826
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50101,412,1.15 [0.98-1.36],0.0957952503976819
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,49813,124,1.25 [0.93-1.67],0.1339992104495314
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza,46386,229,1.55 [1.28-1.87],9.040421032818108e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),46381,224,1.53 [1.26-1.86],2.2506130890850504e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),34489,225,1.26 [0.99-1.58],0.0551740388684626
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,50051,540,0.79 [0.68-0.93],0.0042301387074925
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37151,3409,1.16 [1.09-1.23],9.815545066146645e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37622,3358,1.16 [1.09-1.23],1.9874471840370148e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),49524,267,1.32 [1.09-1.59],0.003699014644672
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",46316,159,1.51 [1.20-1.90],0.0004441481339724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bronchiectasis,43654,691,1.53 [1.37-1.72],3.2278464378066563e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43075,112,1.34 [1.00-1.79],0.0514765431257421
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,48353,5390,1.25 [1.19-1.30],2.598562717231402e-23
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",47628,137,0.84 [0.62-1.14],0.2628029724069689
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,47790,299,0.99 [0.81-1.21],0.911328508719833
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49920,2313,1.43 [1.35-1.52],7.954922989289884e-32
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,47703,212,0.86 [0.67-1.10],0.2316755882091474
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,46300,10224,1.16 [1.12-1.20],3.026471874293364e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48207,716,1.02 [0.90-1.16],0.758044290983669
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,48215,608,1.51 [1.35-1.68],1.1749796179346188e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Emphysema,43571,608,1.88 [1.69-2.09],2.042920671947298e-31
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47805,550,2.51 [2.28-2.75],7.939307897638784e-81
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,49872,3715,1.30 [1.24-1.37],5.384562189621615e-24
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,47869,614,2.40 [2.19-2.64],7.049418684292351e-77
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Later onset COPD,48382,1705,1.40 [1.30-1.50],1.7380850986684166e-20
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,50283,637,1.17 [1.03-1.33],0.0155753662047368
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,47693,202,0.86 [0.67-1.11],0.2520403462426822
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,49820,1867,1.29 [1.20-1.39],6.039082797669335e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,49848,3852,1.24 [1.18-1.31],9.194916098644496e-17
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,49115,1624,0.95 [0.87-1.04],0.2508284917540573
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other pleural conditions,46098,102,1.55 [1.15-2.10],0.0039945575874534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50136,768,2.16 [1.98-2.36],2.0559235956716045e-66
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,50101,2520,1.26 [1.19-1.34],2.329276862883316e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,47912,1916,1.22 [1.13-1.31],1.398268074754972e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural plaque,46295,299,1.40 [1.17-1.67],0.0002239575226994
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",49387,3230,1.31 [1.24-1.38],8.3274361584006865e-22
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,50159,513,1.03 [0.89-1.20],0.6520709098959461
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumothorax,46223,227,1.34 [1.09-1.65],0.0050506836889892
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pollen allergy,50261,462,0.74 [0.62-0.88],0.000779538939692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,49496,128,1.43 [1.10-1.87],0.0082991713877586
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,34371,107,1.73 [1.32-2.26],7.18033646877129e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,49781,1828,1.29 [1.20-1.39],7.561959341536738e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,48033,542,0.79 [0.67-0.93],0.0041278777959209
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Viral pneumonia,46635,478,1.27 [1.10-1.47],0.0015882163504401
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",49552,395,1.26 [1.07-1.48],0.0056264389743885
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23203,216,1.23 [0.98-1.54],0.0735986375889143
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35525,126,1.12 [0.84-1.50],0.4431824160759768
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute appendicitis,49995,286,1.04 [0.85-1.27],0.7186505820566986
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute gastritis,37874,180,1.12 [0.87-1.44],0.3787157065159168
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,46727,346,1.10 [0.92-1.32],0.3079321871565503
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute peritonitis,49395,181,1.10 [0.86-1.41],0.4465522259115454
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,48578,144,1.09 [0.85-1.41],0.5067312475998174
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,38534,840,1.05 [0.93-1.18],0.4620770792956651
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",46577,196,1.10 [0.87-1.40],0.4237018388011473
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",49489,196,1.10 [0.87-1.39],0.4409434317907147
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholecystitis,46770,389,1.05 [0.89-1.25],0.5654122411779943
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholelithiasis,48307,1926,1.02 [0.94-1.10],0.6394355070870917
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic gastritis,38288,594,1.02 [0.88-1.17],0.8208189914469364
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,46477,96,0.94 [0.67-1.32],0.7134860314015715
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",50028,196,1.19 [0.95-1.50],0.1353782592121269
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,47191,240,1.14 [0.91-1.42],0.2672897399077092
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Collagenous colitis,47034,159,1.28 [1.00-1.65],0.0527999763479523
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50008,362,0.94 [0.78-1.13],0.4973862256886422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Constipation,49810,3260,1.04 [0.98-1.10],0.2466815963068523
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn disease,47057,182,1.20 [0.94-1.54],0.136990485833648
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49618,132,1.15 [0.86-1.54],0.3305222681080812
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47047,172,1.15 [0.89-1.48],0.2956095631210404
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Dental caries,48880,445,1.01 [0.86-1.18],0.9503017703698308
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,45179,4338,1.06 [1.01-1.12],0.0211470206337263
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of appendix,50066,357,1.07 [0.90-1.29],0.4463013031717916
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,50071,1637,1.05 [0.97-1.14],0.2400337615464388
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",46080,8386,1.05 [1.01-1.09],0.0077383007571263
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49498,1063,1.01 [0.91-1.13],0.7941504115626579
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50136,922,1.08 [0.97-1.21],0.1718397441433046
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48653,218,0.95 [0.75-1.20],0.6677152839918965
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,48368,130,0.93 [0.69-1.26],0.6420978447853833
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49708,2757,1.09 [1.02-1.16],0.0094778494473324
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of tongue,48398,215,1.04 [0.83-1.32],0.71014309660607
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49088,2707,1.03 [0.96-1.10],0.3687948474889346
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,41534,6135,1.01 [0.97-1.06],0.5346708037395234
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,38083,389,1.14 [0.96-1.35],0.1335063968782693
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50144,312,1.04 [0.86-1.26],0.6738581994518107
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50131,106,0.76 [0.53-1.09],0.1336779963957809
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,48672,238,1.15 [0.93-1.42],0.1967657649134282
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35686,287,0.99 [0.80-1.21],0.898916523559399
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,38764,1070,1.01 [0.91-1.12],0.8511858811637876
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastric ulcer,38393,699,1.10 [0.97-1.24],0.1553888940140667
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,42539,4845,1.06 [1.01-1.11],0.0241938636312635
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38741,1047,1.09 [0.99-1.21],0.0861478009923052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,38942,16119,1.02 [0.99-1.05],0.1988220017340925
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,GI-bleeding,49216,2265,1.10 [1.02-1.18],0.008763642366249
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,48540,105,0.82 [0.58-1.15],0.2470738280105141
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,37301,2455,1.03 [0.96-1.10],0.4315669692891036
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",48555,121,1.24 [0.93-1.64],0.1354246681043633
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Hernia,47143,6302,1.02 [0.98-1.07],0.3356571748235891
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impacted teeth,50144,98,0.85 [0.59-1.24],0.4050881873274108
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impaction of intestines,35510,111,0.93 [0.67-1.30],0.6911569144664775
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,42585,1744,0.92 [0.84-1.00],0.0483222981649262
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41041,200,0.98 [0.76-1.26],0.8721316095711735
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,35588,189,0.88 [0.68-1.14],0.3180167847016114
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47226,275,1.16 [0.95-1.43],0.1543393875964398
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36471,1072,1.12 [1.01-1.24],0.03838038761395
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,50249,720,1.03 [0.91-1.17],0.6352609604821742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48344,1469,1.12 [1.02-1.22],0.0139827626879471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48827,1952,1.11 [1.03-1.20],0.0060728193311804
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38058,364,1.05 [0.88-1.26],0.5709045453265622
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophagitis,38866,1172,1.13 [1.03-1.25],0.0134531420367756
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50209,265,0.98 [0.79-1.21],0.8547874038926702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,40973,132,1.34 [1.01-1.78],0.0400906065224654
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38054,2655,1.07 [1.00-1.14],0.0586194619071575
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46932,551,0.98 [0.85-1.14],0.8230017352784958
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,46685,304,0.95 [0.78-1.16],0.6055706096805731
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,38804,3405,1.11 [1.05-1.17],0.0005411786813036
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,46393,10994,1.03 [1.00-1.07],0.0706315475101163
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48352,402,0.96 [0.81-1.14],0.6480938393741735
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,49773,1339,1.04 [0.95-1.15],0.3601900064120461
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38975,1281,1.13 [1.03-1.24],0.0126416251831558
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,46672,291,1.22 [1.01-1.47],0.0414526763542166
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50003,789,1.08 [0.95-1.22],0.2385684107815995
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39540,1846,1.09 [1.00-1.18],0.0433542531064
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,49244,2293,1.10 [1.02-1.18],0.0080950123935781
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48786,351,1.18 [0.99-1.40],0.0692094615564813
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,38747,3348,1.04 [0.98-1.11],0.1572598243581184
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),41619,3925,1.10 [1.04-1.16],0.0007786497606261
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,48623,189,0.91 [0.70-1.17],0.4628701384917038
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48592,1717,1.12 [1.03-1.22],0.0058332622615138
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36065,666,1.19 [1.05-1.35],0.0068606580649235
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50112,123,0.73 [0.52-1.03],0.075955580185553
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36353,954,1.10 [0.98-1.23],0.0917907043909867
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47238,287,0.94 [0.77-1.16],0.5728681547575776
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,50285,110,0.97 [0.70-1.36],0.865395725636557
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,48443,223,1.07 [0.85-1.34],0.5629675225485965
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Toxic colitis,46983,108,1.16 [0.84-1.60],0.3690154134235978
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38210,516,1.02 [0.88-1.19],0.7551702146109175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,47182,307,0.95 [0.77-1.16],0.5995963829710795
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47130,255,0.92 [0.73-1.14],0.4428055803697408
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,41367,526,0.98 [0.84-1.14],0.7686264093426739
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,35743,344,1.17 [0.98-1.40],0.0788692513088922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ventral hernia,41340,499,1.12 [0.96-1.29],0.1509364502676943
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Volvulus,35558,159,1.02 [0.77-1.34],0.9089565384940972
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,50148,576,0.96 [0.83-1.12],0.598398159964078
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,49680,139,1.06 [0.79-1.42],0.6999349526201908
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46310,311,1.04 [0.85-1.27],0.6885880108212391
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49056,1349,1.11 [1.01-1.21],0.0294084212002555
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48045,338,1.01 [0.84-1.21],0.9479914422010614
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,46788,789,1.16 [1.03-1.30],0.011920137715544
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,49707,538,1.08 [0.93-1.24],0.3264398809290235
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50109,940,1.08 [0.97-1.21],0.1517485819381911
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,49263,94,1.09 [0.76-1.56],0.6379957503492399
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,47263,6239,1.09 [1.04-1.14],0.0001074520596135
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49419,870,1.13 [1.01-1.27],0.0360806938891621
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49166,617,1.16 [1.01-1.32],0.0316656037654413
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,49538,1831,1.09 [1.01-1.18],0.0362733680199265
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",50276,105,1.00 [0.70-1.42],0.9998463387288902
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,46112,113,1.45 [1.10-1.93],0.0094358691470733
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48650,101,1.09 [0.78-1.53],0.6030002720789446
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,49688,519,1.07 [0.92-1.24],0.3581515033511999
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46884,885,1.11 [0.99-1.24],0.0883218880324155
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,46122,123,1.11 [0.82-1.50],0.500666768321675
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,50135,166,1.11 [0.85-1.43],0.4479907440431563
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,48078,371,1.10 [0.92-1.31],0.2993609983204751
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49916,375,1.17 [0.98-1.38],0.0751354045915843
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,49293,124,1.35 [1.02-1.78],0.0336971476879472
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,46127,128,0.79 [0.57-1.10],0.161231070834763
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,49175,3176,1.08 [1.02-1.15],0.0118380636878387
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46955,956,1.11 [0.99-1.24],0.0680620978607164
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,46129,130,1.13 [0.85-1.52],0.3947530731040911
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,50136,595,1.15 [1.00-1.32],0.0503247528189916
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,49302,133,1.11 [0.84-1.49],0.4586751105167648
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50029,488,1.17 [1.01-1.36],0.036230420311569
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,50203,631,0.98 [0.85-1.13],0.7994657438671084
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46244,245,1.01 [0.80-1.26],0.9525578969273586
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46525,526,0.89 [0.76-1.04],0.1562536800754431
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,50182,610,0.97 [0.84-1.12],0.6933220262775732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",46457,458,1.19 [1.02-1.38],0.0228569726138689
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,50244,275,1.07 [0.87-1.31],0.522121021298876
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,43135,211,0.98 [0.77-1.26],0.8983953420844997
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,45799,10969,1.02 [0.99-1.06],0.2152150819164467
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,43044,8214,1.02 [0.98-1.06],0.378596724277636
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,43068,144,0.80 [0.59-1.08],0.1426762806545387
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43613,297,1.20 [1.00-1.45],0.0560698615826246
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43666,350,1.03 [0.86-1.24],0.7506239673086584
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,49818,180,1.06 [0.82-1.36],0.6709921774776534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",43509,193,1.18 [0.94-1.49],0.1509469292541745
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37040,2210,1.08 [1.00-1.16],0.0559339800980707
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50041,367,0.99 [0.82-1.18],0.8793881410406541
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44187,871,1.08 [0.96-1.21],0.2089087095138891
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,42532,14122,1.01 [0.98-1.04],0.3860099391509592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46446,225,0.95 [0.76-1.20],0.688845408340846
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,43218,294,1.00 [0.82-1.22],0.9771012635991306
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44033,1109,0.98 [0.88-1.09],0.7525721415905562
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,48502,5186,1.05 [1.01-1.10],0.0300779816004315
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43455,531,1.08 [0.93-1.25],0.3139852566803622
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,43347,423,1.12 [0.95-1.31],0.1821736236497402
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43185,261,0.80 [0.63-1.00],0.0543256434144178
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,49065,130,0.95 [0.70-1.29],0.7390558362810739
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,38108,3278,0.97 [0.91-1.03],0.3312163782207583
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35998,1168,1.10 [0.99-1.22],0.0626837078553499
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50163,1152,1.09 [0.98-1.20],0.10256135104243
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,34973,143,0.90 [0.66-1.23],0.521346460763207
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35483,653,0.94 [0.81-1.08],0.3563304188358671
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43517,593,0.87 [0.75-1.01],0.0688899714436342
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36064,1234,1.01 [0.91-1.11],0.913626105777747
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,43424,108,1.21 [0.89-1.66],0.2257397165033872
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44547,1231,1.14 [1.04-1.25],0.0075024459011001
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43913,597,1.11 [0.97-1.28],0.1400258771688215
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35985,1155,1.00 [0.90-1.11],0.9963173716868926
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,43078,154,1.03 [0.78-1.37],0.8122336163924316
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",43046,122,1.10 [0.81-1.49],0.5559838285652986
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,46356,135,1.07 [0.80-1.44],0.6243710297272129
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,49547,3326,1.06 [1.00-1.12],0.0565119174838835
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,48403,2182,1.06 [0.99-1.14],0.1160659611175773
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50025,878,1.24 [1.11-1.38],0.0001141955829032
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,39672,4842,1.07 [1.02-1.13],0.0046054647520646
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,34953,123,1.18 [0.86-1.62],0.2979824462148709
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,43106,182,1.08 [0.84-1.39],0.5531486142505233
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,34925,95,1.21 [0.86-1.71],0.2749593464141153
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35077,247,0.84 [0.67-1.06],0.1488294369510617
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46693,472,1.07 [0.91-1.25],0.4221942061112341
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,46962,741,1.10 [0.97-1.25],0.1399817533929643
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,50241,197,1.17 [0.92-1.48],0.198784250273488
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",46831,3515,1.07 [1.01-1.13],0.0222920365550217
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43116,192,1.03 [0.80-1.33],0.8064126020379692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35100,270,0.91 [0.73-1.14],0.4321827300511516
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44729,1413,1.08 [0.99-1.18],0.0961950978068018
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39007,4177,1.01 [0.96-1.07],0.6023604834486986
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,49111,176,1.20 [0.94-1.53],0.1533253667348466
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,50269,133,1.08 [0.81-1.46],0.5913444569770827
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43083,159,0.96 [0.73-1.26],0.774743355092296
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45351,2427,1.06 [0.99-1.14],0.0908559270130388
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,43097,173,1.02 [0.79-1.32],0.8733967014763309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,37981,3151,1.12 [1.05-1.19],0.0002425276342969
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46440,219,1.05 [0.83-1.32],0.6972835825363639
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,43029,105,0.95 [0.67-1.36],0.7909336641226827
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,43620,304,1.14 [0.94-1.38],0.1820021572913152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44005,1081,1.05 [0.95-1.17],0.3363420270002771
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49624,689,1.17 [1.03-1.33],0.0181563632105466
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,44434,1118,1.12 [1.01-1.23],0.0302674777776409
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50049,854,1.23 [1.10-1.38],0.0002005112904965
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,50262,107,1.34 [0.98-1.82],0.0649554804241403
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43295,371,1.05 [0.87-1.26],0.6184610700028615
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39822,1463,1.10 [1.01-1.20],0.0301332588503196
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44061,1137,1.06 [0.96-1.18],0.2442743489318761
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43373,449,1.10 [0.94-1.29],0.242966016374996
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",34936,106,0.97 [0.69-1.37],0.8838421587041708
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,39657,4827,1.11 [1.05-1.16],6.82249118310494e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36101,1271,1.03 [0.94-1.14],0.5295558392493027
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,49391,456,1.12 [0.95-1.31],0.1688027013594327
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",50175,131,1.25 [0.94-1.66],0.1281534817926962
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",46099,99,0.97 [0.68-1.37],0.8584875907537383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,34965,135,1.11 [0.82-1.49],0.4951816085003301
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,43517,201,1.39 [1.12-1.73],0.0031769156740222
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35719,889,1.24 [1.11-1.39],9.874401395677432e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43527,603,1.07 [0.93-1.23],0.3733963170567639
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43808,492,1.02 [0.87-1.19],0.7981016066608877
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,43691,375,1.10 [0.92-1.31],0.2945434193202412
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,39371,117,1.08 [0.79-1.48],0.6282600430046651
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",50270,115,1.31 [0.98-1.77],0.0718724637095215
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44075,1151,0.98 [0.88-1.09],0.7088368568727212
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],49113,178,1.49 [1.18-1.88],0.0008288746860056
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,47940,5016,1.03 [0.98-1.08],0.2363005185343635
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43182,258,1.12 [0.90-1.38],0.3029099659436786
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44388,1072,1.10 [0.99-1.22],0.0682622769138556
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,47579,448,1.08 [0.92-1.27],0.3213001043338483
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,43715,399,1.14 [0.97-1.35],0.1185806262580685
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,46353,3037,1.10 [1.04-1.17],0.0016123023944711
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45314,1998,1.14 [1.06-1.23],0.0003622466787442
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],43028,104,1.23 [0.89-1.70],0.2010973737814928
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49191,256,1.26 [1.03-1.54],0.0278615798983765
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43242,318,1.14 [0.94-1.38],0.1802196280025086
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,43073,149,1.17 [0.89-1.54],0.25918090813032
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),34944,114,1.35 [1.00-1.82],0.0518585190419347
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,48268,3058,1.23 [1.16-1.30],5.600956824943095e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20292,100,0.84 [0.58-1.23],0.3761366750507114
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26439,112,1.00 [0.71-1.40],0.9973995635797605
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49687,620,1.06 [0.92-1.22],0.4060816818754525
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,49228,161,1.03 [0.78-1.35],0.8402677649788257
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,48182,2972,1.22 [1.15-1.30],7.435955908279352e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,49884,161,1.38 [1.09-1.76],0.0082897596225928
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,49825,587,1.08 [0.94-1.24],0.2957654637703972
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cystitis,44319,459,0.96 [0.82-1.13],0.6239975321027376
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dialysis,45365,155,1.40 [1.09-1.81],0.0090990527784362
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,21916,3238,1.04 [0.98-1.11],0.1951046868393883
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26666,339,1.07 [0.89-1.29],0.4789884961898829
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20368,176,1.04 [0.79-1.35],0.7969312174646692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20583,391,1.05 [0.88-1.26],0.5931738375093054
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21189,997,0.91 [0.81-1.02],0.1105515916350149
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,41979,10454,1.05 [1.02-1.09],0.0020746221216508
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,49890,167,1.36 [1.06-1.73],0.015329102823009
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,18876,198,1.14 [0.89-1.45],0.2978160566695601
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,45187,564,0.92 [0.79-1.07],0.2632199740505448
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21216,2538,1.05 [0.98-1.13],0.14164471945106
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26597,393,1.04 [0.87-1.24],0.6542296271709709
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18909,231,1.01 [0.80-1.27],0.9284415148615552
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,26670,126,1.12 [0.82-1.53],0.4622455907238749
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20493,301,1.01 [0.82-1.25],0.9026618531425944
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44010,150,1.09 [0.83-1.43],0.538769897354052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22629,2437,0.99 [0.92-1.06],0.7693836613684505
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18788,110,1.32 [0.98-1.79],0.0698476005261383
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20332,140,0.91 [0.67-1.24],0.539137539289233
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",50281,123,0.81 [0.59-1.13],0.2173799435547732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",50290,127,1.12 [0.84-1.50],0.4395768490116643
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,48274,4414,1.09 [1.03-1.14],0.001458317845005
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45248,1388,1.12 [1.03-1.23],0.0116916446779625
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26444,117,0.98 [0.71-1.37],0.911777662515746
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50172,934,1.16 [1.04-1.29],0.0080628955241179
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18984,306,1.27 [1.05-1.53],0.0124188080078113
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18957,279,1.01 [0.82-1.24],0.9361063031238076
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,18899,221,0.75 [0.59-0.96],0.0225051158860774
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,50229,137,0.94 [0.69-1.27],0.6794889586857787
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,47265,3405,1.09 [1.03-1.15],0.0040667377487623
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26402,198,1.16 [0.91-1.48],0.2268337211687562
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20346,154,1.04 [0.78-1.38],0.7929337361843934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20557,365,1.03 [0.86-1.24],0.7451067229714857
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20300,108,0.95 [0.68-1.34],0.7700969730420543
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20398,206,1.31 [1.05-1.64],0.0175492155158297
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45281,658,0.90 [0.78-1.03],0.1384981862949668
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,49549,311,1.22 [1.01-1.46],0.0343086899905702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20501,309,1.03 [0.84-1.26],0.7692744246894405
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20297,105,1.04 [0.73-1.47],0.8369212510765862
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20826,634,1.08 [0.94-1.25],0.2514625596402705
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20351,159,0.90 [0.68-1.21],0.4920849552200431
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20778,586,1.05 [0.91-1.22],0.4864470871089457
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,49820,97,1.18 [0.84-1.65],0.33879443617304
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18940,262,0.88 [0.71-1.10],0.2639595779276541
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,49813,5190,1.16 [1.11-1.22],8.174083037877152e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",44853,230,1.09 [0.87-1.37],0.4458272831141472
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45465,255,1.26 [1.03-1.53],0.0243453939353935
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49173,106,0.94 [0.67-1.31],0.7090950175637819
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44294,434,1.18 [1.01-1.38],0.0398206251784284
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49832,765,1.06 [0.94-1.20],0.3174859640440587
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20328,136,1.05 [0.78-1.42],0.7434816225936424
